Holen Sie sich die Stockscreener-App
0.3704
0.01%
0.00035
Schlusskurs vom Vortag:
$0.37
Offen:
$0.355
24-Stunden-Volumen:
2.26M
Relative Volume:
0.84
Marktkapitalisierung:
$9.43M
Einnahmen:
$486.00K
Nettoeinkommen (Verlust:
$-28.43M
KGV:
-0.1314
EPS:
-2.8189
Netto-Cashflow:
$-26.75M
1W Leistung:
+2.71%
1M Leistung:
+19.18%
6M Leistung:
-76.20%
1J Leistung:
-80.63%
1-Tages-Spanne:
$0.355
$0.385
1-Wochen-Bereich:
$0.3487
$0.4565
52-Wochen-Spanne:
$0.2805
$4.30
Vyne Therapeutics Inc Stock (VYNE) Company Profile
Firmenname
Vyne Therapeutics Inc
Sektor
Branche
Telefon
800-775-7936
Adresse
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Vergleichen Sie VYNE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.3704 | 9.42M | 486.00K | -28.43M | -26.75M | -2.8189 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.31 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.47 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.58 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-31 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-11-18 | Eingeleitet | BTIG Research | Buy |
| 2021-12-06 | Fortgesetzt | H.C. Wainwright | Buy |
Vyne Therapeutics Inc Aktie (VYNE) Neueste Nachrichten
Will VYNE Therapeutics Inc. stock benefit from sector rotationJuly 2025 Weekly Recap & Fast Exit/Entry Strategy Plans - newser.com
Forecasting VYNE Therapeutics Inc. price range with options dataWatch List & Fast Gaining Stock Strategy Reports - newser.com
Why VYNE Therapeutics Inc. stock could be next big winner2025 Investor Takeaways & Community Consensus Picks - newser.com
Applying Elliott Wave Theory to VYNE Therapeutics Inc.2025 Major Catalysts & Real-Time Sentiment Analysis - newser.com
EOM Pharmaceutical (OTCMKTS:IMUC) vs. VYNE Therapeutics (NASDAQ:VYNE) Critical Survey - Defense World
Will VYNE Therapeutics Inc. see short term momentumJuly 2025 Summary & Verified Momentum Watchlists - newser.com
Will VYNE Therapeutics Inc. stock split again soonGlobal Markets & Community Shared Stock Ideas - newser.com
Can machine learning forecast VYNE Therapeutics Inc. recoveryWeekly Gains Report & Real-Time Volume Analysis - newser.com
VYNE Therapeutics Inc. stock trendline breakdown2025 AllTime Highs & Safe Capital Growth Tips - newser.com
Using Ichimoku Cloud for VYNE Therapeutics Inc. technicals2025 Market Trends & Safe Swing Trade Setups - newser.com
What candlestick patterns are forming on VYNE Therapeutics Inc.July 2025 Fed Impact & Community Shared Stock Ideas - newser.com
Intraday pattern recognizer results for VYNE Therapeutics Inc.Buy Signal & Low Risk High Reward Ideas - newser.com
What analysts say about VYNE Therapeutics Inc stockAI-Driven Market Analysis & Superior Capital Trading Plans - earlytimes.in
Will VYNE Therapeutics Inc. outperform the marketWeekly Volume Report & AI Driven Price Predictions - newser.com
Will VYNE Therapeutics Inc. bounce back from current supportBond Market & Daily Growth Stock Tips - newser.com
Exit strategy if you’re trapped in VYNE Therapeutics Inc.July 2025 Final Week & High Accuracy Trade Signal Alerts - newser.com
Is VYNE Therapeutics Inc a good long term investmentTake Profit Strategies & Low Risk Trading Growth - earlytimes.in
Sentiment analysis tools applied to VYNE Therapeutics Inc.2025 Sector Review & Safe Entry Zone Tips - newser.com
How high can VYNE Therapeutics Inc. stock goWeekly Investment Recap & Weekly Top Stock Performers List - newser.com
Market reaction to VYNE Therapeutics Inc.’s recent news2025 Market Overview & Daily Price Action Insights - newser.com
Finanzdaten der Vyne Therapeutics Inc-Aktie (VYNE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):